Nitrofurantoin is a well-established antibiotic used to treat and prevent urinary tract infections (UTIs) [1]. It is effective against a range of bacteria commonly found in the urinary tract, including Escherichia coli and Enterococcus faecalis [2]. Its mechanism of action involves damaging bacterial DNA and disrupting metabolic processes [3].
How does nitrofurantoin work against bacteria?
Nitrofurantoin functions as a prodrug, meaning it is converted into active metabolites within bacterial cells [3]. These metabolites interfere with bacterial enzymes, including DNA gyrase and flavoproteins, essential for DNA replication, transcription, cell division, and aerobic metabolism [4]. This multifaceted disruption leads to bacterial cell death.
What types of infections does nitrofurantoin treat?
Nitrofurantoin is primarily prescribed for the treatment of acute uncomplicated cystitis, commonly known as a bladder infection [1]. It is also frequently used as a prophylactic agent to prevent recurrent UTIs in individuals prone to them [5]. Its use is generally limited to uncomplicated UTIs due to concerns about resistance development and potential side effects in more severe infections [6].
How long does it take for nitrofurantoin to work?
Patients typically experience relief from UTI symptoms within a few days of starting nitrofurantoin treatment [1]. For treatment, a course of nitrofurantoin usually lasts for seven days [5]. For prevention, it may be taken daily or every other day for extended periods [5].
Are there side effects associated with nitrofurantoin?
Common side effects of nitrofurantoin include nausea, vomiting, headache, and diarrhea [7]. More serious, though less common, side effects can involve pulmonary reactions, characterized by fever, chills, cough, and shortness of breath, and hepatic reactions, such as jaundice or hepatitis [7]. Long-term use has also been associated with potential peripheral neuropathy and, rarely, pulmonary fibrosis [6][7].
What are the risks of taking nitrofurantoin long-term?
Long-term use of nitrofurantoin carries a risk of pulmonary toxicity, which can manifest as acute, subacute, or chronic reactions. These reactions may range from mild, reversible lung inflammation to severe, potentially irreversible pulmonary fibrosis [6]. Hepatic dysfunction and peripheral neuropathy are also potential risks with prolonged treatment [7].
How does nitrofurantoin compare to other UTI antibiotics?
Nitrofurantoin is often a first-line treatment for uncomplicated UTIs, particularly in outpatient settings [8]. Other commonly used antibiotics for UTIs include trimethoprim-sulfamethoxazole and fosfomycin [9]. Nitrofurantoin's efficacy against common UTI pathogens, coupled with a relatively low rate of resistance development compared to some other antibiotics, makes it a valuable option [10]. However, it is generally not recommended for pyelonephritis (kidney infections) or in patients with impaired renal function [6].
When does nitrofurantoin patent protection expire?
Information regarding specific patent expiry dates for nitrofurantoin formulations is available through specialized patent databases. DrugPatentWatch.com tracks patent information for pharmaceuticals, which can provide details on the intellectual property landscape of drugs like nitrofurantoin [11].
Who makes generic versions of nitrofurantoin?
Several pharmaceutical companies manufacture generic versions of nitrofurantoin. These generics are available in various formulations, including capsules and oral suspensions, making the medication accessible to a wide range of patients [12].
Sources:
[1] https://www.nhs.uk/medicines/nitrofurantoin/
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259573/
[3] https://www.sciencedirect.com/topics/medicine-and-health-sciences/nitrofurantoin
[4] https://www.ncbi.nlm.nih.gov/books/NBK538203/
[5] https://www.uptodate.com/contents/nitrofurantoin-drug-information
[6] https://www.idsociety.org/practice-guideline/idsa-guidelines-on-the-management-of-urinary-tract-infection/
[7] https://www.nhs.uk/medicines/nitrofurantoin/side-effects/
[8] https://www.nejm.org/doi/full/10.1056/nejmcp2000942
[9] https://www.clinicalguidelines.scot.nhs.uk/guidelines/primary-care-guidelines/common-prescribing-guidelines/urinary-tract-infection-uti-in-adults/
[10] https://www.contemporyobgyn.net/view/nitrofurantoin-still-a-reliable-choice-for-uti-management
[11] https://drugpatentwatch.com/
[12] https://www.goodrx.com/nitrofurantoin